SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rubius Therapeutics, Inc. – IPO: ‘S-1’ on 6/22/18 – ‘EX-23.1’

On:  Friday, 6/22/18, at 4:47pm ET   ·   Accession #:  1047469-18-4710   ·   File #:  333-225840

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 7/2/18   ·   Latest:  ‘S-1/A’ on 7/9/18   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/22/18  Rubius Therapeutics, Inc.         S-1                   18:11M                                    Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.86M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML    145K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     35K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     98K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    114K 
 6: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    306K 
 7: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     53K 
 8: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     53K 
 9: EX-10.1     Material Contract                                   HTML    264K 
11: EX-10.10    Material Contract                                   HTML     29K 
12: EX-10.11    Material Contract                                   HTML    750K 
13: EX-10.12    Material Contract                                   HTML    261K 
14: EX-10.13    Material Contract                                   HTML    243K 
15: EX-10.14    Material Contract                                   HTML     74K 
16: EX-10.15    Material Contract                                   HTML     73K 
10: EX-10.4     Material Contract                                   HTML     19K 
17: EX-21       Subsidiaries                                        HTML      8K 
18: EX-23.1     Consent of Experts or Counsel                       HTML      9K 


EX-23.1   —   Consent of Experts or Counsel
Exhibit Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Exhibit 23.1
"Consent of independent registered public accounting firm
"QuickLinks

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of independent registered public accounting firm

We hereby consent to the use in this Registration Statement on Form S-1 of Rubius Therapeutics, Inc. of our report dated April 13, 2018 relating to the financial statements of Rubius Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
June 22, 2018


 C: 


QuickLinks


Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
Filed on:6/22/18None on these Dates
4/13/18
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  Rubius Therapeutics, Inc.         10-K       12/31/22   77:7.2M
 6/08/22  Rubius Therapeutics, Inc.         S-3                    6:1M                                     Toppan Merrill/FA
 5/10/22  Rubius Therapeutics, Inc.         S-8         5/10/22    4:63K                                    Toppan Merrill/FA
 2/25/22  Rubius Therapeutics, Inc.         10-K       12/31/21   74:10M                                    Toppan Merrill Bridge/FA
 5/10/21  Rubius Therapeutics, Inc.         S-8         5/10/21    3:110K                                   Toppan Merrill Bridge/FA
 2/23/21  Rubius Therapeutics, Inc.         10-K       12/31/20   82:12M                                    Toppan Merrill Bridge/FA
Top
Filing Submission 0001047469-18-004710   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 4:18:22.1pm ET